LINC01322 and nonpapillary renal cell carcinoma: Interestingly, LINC01322 was also up regulated in The Cancer Genome Atlas Program (TCGA) cohorts for pRCC, ccRCC, head and neck squamous cell carcinoma (HNSC), and glioblastoma multiforme (GBM) (Fig. 2).